Jon Coles


Jon has extensive experience advising clients on a broad range of issues, including mergers and acquisitions, issues management and IPOs, particularly within the healthcare and life sciences sectors. In addition to client activity, Jon is Brunswick’s Compliance Partner.

Jon joined Brunswick in 1990, prior to which he was a senior manager in Corporate Finance at Price Waterhouse. He graduated in Physiology and Biochemistry from University of Southampton.

Jon has advised on the Astra and Zeneca merger, all the Celltech transactions, the Bayer Schering and Sanofi-Aventis mergers, the De La Rue and Forth Ports' defenses and many others. He has advised on more than 25 IPOs and listings, including Al Noor Hospitals Group, Anglo American, DP World, Harvey Nash, Hikma Pharmaceuticals, Scottish Power and Syngenta.